site stats

Editas target price

Web1 day ago · Lloyds (LON: LLOY) share price dropped sharply on Thursday even after the encouraging UK GDP numbers. The shares dropped to a low of 47.95p, which was … WebApr 13, 2024 · Editas Medicine, Inc. has a 52 week low of $6.33 and a 52 week high of $19.97. The stock has a market cap of $438.65 million, a price-to-earnings ratio of -1.98 and a beta of 1.86. The company...

EDIT Price Target 2024 Editas Medicine Analyst Ratings

WebEditas Medicine, Inc. (EDIT) Stock Price, News, Quote & History - Yahoo Finance My Portfolio Personal Finance Industries U.S. markets closed S&P Futures 0.00(0.00%) … WebApr 12, 2024 · Recent reports have lowered Editas Medicine’s price target from $36.00 to $30.00 and raised it from $13.00 to $15.00. Editas Medicine’s stock opened at $6.71 and has a 50-day moving average of $8.70 and a 200-day moving average of $9.86. The company’s market capitalization is $462.79 million, and it has a PE ratio of -2.09 and a … reliamark oring https://brain4more.com

Editas Medicine Sees Unusually Large Options Volume …

WebFind real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business. EDIT - Editas Medicine Inc Stock quote - … WebApr 10, 2024 · Editas Medicine Inc’s ( EDIT) price is currently down 8.55% so far this month. During the month of April, Editas Medicine Inc’s stock price has reached a high of $7.21 and a low of $6.45. Over the last year, Editas Medicine Inc has hit prices as high as $20.04 and as low as $6.70. Year to date, Editas Medicine Inc’s stock is down 75.03%. Web14 hours ago · The stock rose 0.2% to close at $94.30, with Snyder’s new price target implying further 15.6% upside. It has slipped 2.7% since closing at a five-year high of … produits h2o catalogue

EDIT : Editas Medicine stock forecast 2024 - 2025 - 2030

Category:Lloyds share price target lifted ahead of bank earning season

Tags:Editas target price

Editas target price

Editas Medicine Sees Unusually Large Options Volume …

WebApr 13, 2024 · Furthermore, Editas Medicine Inc. (EDIT)’s beta value is 1.85, and its average true range (ATR) is 0.43. The company’s stock has been forecasted to trade at an average price of $12.88 over the course of the next 52 weeks, with a … WebEditas Medicine, Inc. (EDIT) Stock Price, News, Quote & History - Yahoo Finance My Portfolio Personal Finance Industries U.S. markets closed S&P Futures 0.00(0.00%) Dow Futures 33,683.00...

Editas target price

Did you know?

Web2 days ago · Price Target Based on short-term price targets offered by 15 analysts, the average price target for Editas Medicine comes to $13.67. The forecasts range from a … WebFeb 6, 2024 · Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The …

WebApr 14, 2024 · Credit Suisse Group boosted their price target on shares of Editas Medicine from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on … WebApr 16, 2024 · InvestorPlace - Stock Market News, Stock Advice & Trading Tips Goldman Sachs Just Put Editas Stock on Sale — Buy the Dip Nasdaq Skip to main content Logo …

WebApr 4, 2024 · The Editas Medicine stock prediction results are shown below and presented as a graph, table and text information. Editas Medicine stock forecasts are adjusted once … WebEditas Medicine's current and average target prices are 9.57 and 52.20, respectively. The current price of Editas Medicine is the price at which Editas Medicine is currently …

WebApr 14, 2024 · Editas Medicine Price Performance EDIT stock opened at $7.65 on Friday. Editas Medicine has a one year low of $6.33 and a one year high of $19.97. The stock has a market cap of $527.62...

WebApr 16, 2024 · Editas Medicine's share price as of the closing of business day yesterday was $40.98. And even after today's sell-off, Editas Medicine stock is priced at $34.21 (as … produits landishWebApr 14, 2024 · The Athletic’s Diante Lee has the Bears drafting Tennessee offensive tackle Darnell Wright with the No. 9 pick. Though Johnson is off the board, there’s no shortage … produit sheinWebIn the context of stocks in the mid market cap category, EDITAS MEDICINE INC's average analyst price target is higher than 1512.08% of them. Stocks similar to EDITAS … reliaguard incWebJun 6, 2024 · The 41 Wall Street analysts offering Editas Medicine stock forecast in the last 6 months have average price target of $18.54 with a high forecast of $43.0 and a low … produits isomarineproduits gagnants dropshipping 2023WebApr 10, 2024 · US$503.3m 7D -9.0% 1Y -60.2% Updated 27 Mar, 2024 Data Company Financials + 17 Analysts EDIT Stock Overview About the company Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. reliamed blood pressure monitor error 3WebApr 13, 2024 · Editas Medicine Inc. (NASDAQ:EDIT) shares, rose in value on Wednesday, 04/12/23, with the stock price down by -5.22% to the previous day’s close as strong … reliamed portable ultrasound machine